All In MedTech

Device Trial Radar · NCT01765322

The Effect of Laser-assisted Zona Thinning on the Implantation Rate in the Women of Advanced Age

Center of Assisted Reproductive Technology

Last checked: Nov 19, 2026Latest source record: Nov 27, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 150 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

150

Planned (sponsor's estimate)

Start

Nov 2013

Primary completion

Jan 2015

Study completion Jul 2015

Sponsor

Lead sponsor
Shanxi Provincial Maternity and Children's HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jan 10, 2013

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Double (participant, outcomes assessor)
Primary purpose
Treatment
Who can join
Female only, from 35 years, up to 46 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine whether laser-assisted zona thinning improve the implantation rate of the women of advanced age in the first IVF/ICSI cycles

Conditions

  • Female Urogenital Diseases

Interventions

  • ZILOS-TK IVOS AnalyzerDevice

    The subjects are going to participate the treatment of assisted hatching in vitro fertilization by Zona Infrared Laser Optical System (ZILOS-TK,Hamilton Thorne Biosciences,USA)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The implantation rateTime frame: 30 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Maternal and Children Health Care Hospital

    Xi'an, Shaanxi, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.